Secondary Stock Offerings
By The Online Investor Staff, updated Thu., Sep. 23, 1:08 AM
| This Slide: #1 of 25 |
Slide #1. Leap Therapeutics, Inc. — Secondary Offering
Company:
Leap Therapeutics, Inc. (NASDAQ:LPTX)
Date announced:
9/22/2021
Shares Offered:
31,600,000
Date of Pricing:
9/22/2021
Price Per Share:
$2.85
Secondary Offering Details:
Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the pricing of an underwritten public offering of its common stock at a public offering price of $2.85 per share and of pre-funded warrants to purchase shares of its common stock at a public offering price of $2.849 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.001 per share exercise price for each pre-funded warrant. The gross proceeds to Leap from this offering are expected to be approximately $90 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Leap. All shares of common stock and pre-funded warrants to be sold in the offering will be offered by Leap. In addition, Leap has granted the underwriters a 30-day option to purchase up to an aggregate of an additional 4,740,000 shares of its common stock at the public offering price per share, less underwriting discounts and commissions. The offering is expected to close on or about September 24, 2021, subject to satisfaction of customary closing conditions.
Leap Therapeutics is a biopharmaceutical company developing therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Co.'s two clinical stage programs are: DKN-01, which is a monoclonal antibody that inhibits Dickkopf-related protein 1, a protein that regulates the Wnt signaling pathways and enables tumor cells to profilerate and spread, as well as suppresses the immune system from attacking the tumor; and TRX518, which is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor, a receptor found on the surface of a range of immune cells.
Open the LPTX Page at The Online Investor »
|
|||||||||||||||||||||
Open the LPTX Page at The Online Investor (in a new window) »
List of Secondary Stock Offerings in this Slideshow:
9/7/2021:
Company: Option Care Health, Inc. (OPCH)
Shares Offered: 9,200,000
More: offering details »
9/8/2021:
Company: Digital Realty (DLR)
Shares Offered: 6,250,000
More: offering details »
9/8/2021:
Company: Fortress Transportation and Infrastructure Investors LLC (FTAI)
Shares Offered: 12,000,000
More: offering details »
9/8/2021:
Company: Agree Realty Corporation (ADC)
Shares Offered: 7,000,000
More: offering details »
9/9/2021:
Company: Destination XL Group, Inc. (DXLG)
Shares Offered: 5,733,076
More: offering details »
9/9/2021:
Company: Clarivate Plc (CLVT)
Shares Offered: 25,000,000
More: offering details »
9/9/2021:
Company: WillScot Mobile Mini Holdings Corp. (WSC)
Shares Offered: 21,410,019
More: offering details »
9/13/2021:
Company: Avantor, Inc. (AVTR)
Shares Offered: 20,833,334
More: offering details »
9/13/2021:
Company: Leslie's, Inc. (LESL)
Shares Offered: 15,820,000
More: offering details »
9/13/2021:
Company: Academy Sports and Outdoors, Inc. (ASO)
Shares Offered: 18,645,602
More: offering details »
9/13/2021:
Company: BRP Group, Inc. (BRP)
Shares Offered: 8,000,000
More: offering details »
9/13/2021:
Company: Opendoor Technologies Inc. (OPEN)
Shares Offered: 28,000,000
More: offering details »
9/13/2021:
Company: VORNADO REALTY TRUST (VNO)
Shares Offered: 12,000,000
More: offering details »
9/14/2021:
Company: NeoGames S.A. (NGMS)
Shares Offered: 3,457,346
More: offering details »
9/14/2021:
Company: Avalo Therapeutics, Inc. (AVTX)
Shares Offered: 12,500,000
More: offering details »
9/14/2021:
Company: Nuwellis, Inc. (NUWE)
Shares Offered: 3,483,120
More: offering details »
9/14/2021:
Company: Hut 8 Mining Corp. (HUT)
Shares Offered: 17,550,000
More: offering details »
9/14/2021:
Company: Live Nation Entertainment, Inc. (LYV)
Shares Offered: 5,239,259
More: offering details »
9/15/2021:
Company: aTyr Pharma, Inc. (LIFE)
Shares Offered: 9,375,000
More: offering details »
9/15/2021:
Company: Callaway Golf Company (ELY)
Shares Offered: 4,000,000
More: offering details »
9/20/2021:
Company: Viridian Therapeutics, Inc. (VRDN)
Shares Offered: 6,185,454
More: offering details »
9/20/2021:
Company: Viridian Therapeutics, Inc. (VRDN)
Shares Offered: 23,126
More: offering details »
9/21/2021:
Company: Safehold Inc. (SAFE)
Shares Offered: 2,000,000
More: offering details »
9/21/2021:
Company: VersaBank (VB.CA)
Shares Offered: 5,500,000
More: offering details »
9/22/2021:
Company: Leap Therapeutics, Inc. (LPTX)
Shares Offered: 31,600,000
More: offering details »
|
|
Avg. Broker Rec.
 
|
Strong Buy (3.75 out of 4) 67th percentile
(ranked higher than approx. 67% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
